Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,196 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Protocol digest of a randomized controlled adaptive Phase II/III trial of neoadjuvant chemotherapy for Japanese patients with oesophagogastric junction adenocarcinoma: Japan Clinical Oncology Group Study JCOG2203 (NEO-JPEG).
Kita R, Yanagimoto Y, Imazeki H, Booka E, Tsushima T, Mizusawa J, Sasaki K, Fukuda H, Kurokawa Y, Takeuchi H, Kato K, Kitagawa Y, Boku N, Yoshikawa T, Terashima M; Stomach Cancer Study Group and Japan Esophageal Oncology Group of the Japan Clinical Oncology Group. Kita R, et al. Among authors: kurokawa y. Jpn J Clin Oncol. 2024 Feb 7;54(2):206-211. doi: 10.1093/jjco/hyad149. Jpn J Clin Oncol. 2024. PMID: 37952093
A Phase I/II trial of radiotherapy concurrent with TS-1 plus cisplatin in patients with clinically resectable type 4 or large type 3 gastric cancer: Osaka Gastrointestinal Cancer Chemotherapy Study Group OGSG1205.
Imano M, Furukawa H, Yokokawa M, Nishimura Y, Kurokawa Y, Satoh T, Sakai D, Yasuda T, Imamoto H, Tujinaka T, Shimokawa T, Shiozaki H; Osaka Gastrointestinal Cancer Chemotherapy Study Group. Imano M, et al. Among authors: kurokawa y. Jpn J Clin Oncol. 2013 Apr;43(4):431-5. doi: 10.1093/jjco/hys239. Epub 2013 Feb 26. Jpn J Clin Oncol. 2013. PMID: 23447812 Clinical Trial.
A phase II trial of trastuzumab combined with irinotecan in patients with advanced HER2-positive chemo-refractory gastric cancer: Osaka Gastrointestinal Cancer Chemotherapy Study Group OGSG1203 (HERBIS-5).
Sakai D, Satoh T, Kurokawa Y, Kudo T, Nishikawa K, Oka Y, Tsujinaka T, Shimokawa T, Doki Y, Furukawa H. Sakai D, et al. Among authors: kurokawa y. Jpn J Clin Oncol. 2013 Aug;43(8):838-40. doi: 10.1093/jjco/hyt083. Epub 2013 Jul 12. Jpn J Clin Oncol. 2013. PMID: 23852648 Clinical Trial.
Gastrectomy plus chemotherapy versus chemotherapy alone for advanced gastric cancer with a single non-curable factor (REGATTA): a phase 3, randomised controlled trial.
Fujitani K, Yang HK, Mizusawa J, Kim YW, Terashima M, Han SU, Iwasaki Y, Hyung WJ, Takagane A, Park DJ, Yoshikawa T, Hahn S, Nakamura K, Park CH, Kurokawa Y, Bang YJ, Park BJ, Sasako M, Tsujinaka T; REGATTA study investigators. Fujitani K, et al. Among authors: kurokawa y. Lancet Oncol. 2016 Mar;17(3):309-318. doi: 10.1016/S1470-2045(15)00553-7. Epub 2016 Jan 26. Lancet Oncol. 2016. PMID: 26822397 Clinical Trial.
1,196 results